Skip to content
World Health Systems Facts

Czechia: Health System Expenditures


Total Health Spending, USD PPP Per Capita (2020): $3,805.14

(Note: “Health spending measures the final consumption of health care goods and services (i.e. current health expenditure) including personal health care (curative care, rehabilitative care, long-term care, ancillary services and medical goods) and collective services (prevention and public health services as well as health administration), but excluding spending on investments. Health care is financed through a mix of financing arrangements including government spending and compulsory health insurance (“Government/compulsory”) as well as voluntary health insurance and private funds such as households’ out-of-pocket payments, NGOs and private corporations (“Voluntary”). This indicator is presented as a total and by type of financing (“Government/compulsory”, “Voluntary”, “Out-of-pocket”) and is measured as a share of GDP, as a share of total health spending and in USD per capita (using economy-wide PPPs).”

Source: OECD (2023), Health spending (indicator). doi: 10.1787/8643de7e-en (Accessed on 24 May 2023).


Current Health Expenditure As Percentage Of Gross Domestic Product, 2020: 9.24%

Source: Global Health Observatory. Current health expenditure (CHE) as percentage of gross domestic product (GDP) (%). Geneva: World Health Organization. Last accessed May 14, 2023.


Current Health Expenditure Per Capita in USD, 2020: $2,120

Source: Global Health Observatory. Current health expenditure (CHE) per capita in US$. Geneva: World Health Organization. Last accessed May 13, 2023.


Out-Of-Pocket Expenditure As Percentage Of Current Health Expenditure, 2020: 11.53%

Source: Global Health Observatory. Out-of-pocket expenditure as percentage of current health expenditure (CHE) (%). Geneva: World Health Organization. Last accessed May 13, 2023.


Out-Of-Pocket Expenditure Per Capita in USD, 2020: $244.3

Source: Global Health Observatory. Out-of-pocket expenditure (OOP) per capita in US$. Geneva: World Health Organization. Last accessed May 13, 2023.


Annual household out-of-pocket payment in current USD per capita, 2020: $244

Source: Global Health Expenditure Database. Health expenditure series. Geneva: World Health Organization. Last accessed May 13, 2023.


Out-of-Pocket Spending as Share of Final Household Consumption, 2019 (%): 2.4%

Source: OECD (2021), Health at a Glance 2021: OECD Indicators, OECD Publishing, Paris, https://doi.org/10.1787/ae3016b9-en.


Remuneration of Doctors, Ratio to Average Wage (2019)
General Practitioners: NA
Specialists: 2.4

Source: OECD (2021), Health at a Glance 2021: OECD Indicators, OECD Publishing, Paris, https://doi.org/10.1787/ae3016b9-en.


Remuneration of Hospital Nurses, Ratio to Average Wage (2019): 1.3
Remuneration of Hospital Nurses, USD PPP (2019): $36,600

Source: OECD (2021), Health at a Glance 2021: OECD Indicators, OECD Publishing, Paris, doi.org/10.1787/ae3016b9-en.


“In 2019, Czechia spent EUR 2,362 per capita (adjusted for differences in purchasing power) on health – substantially lower than the EU weighted average. As a share of GDP, health spending reached 7.8%, which is also below the EU average of 9.9% (Figure 7). However, the share of public financing of health has historically been high in Czechia: at 82% in 2019, it was above the EU average of 79.7%. The main source of health expenditure is SHI [Social Health Insurance] contributions (consisting of wage-based contributions for employees from employers, income-related contributions from self-employed people and state contributions for specific groups of economically inactive people), supplemented by funding from state and territorial budgets, EU funds and private expenditure. Out-of-pocket expenditure consists of cost-sharing, such as co-payments for prescribed pharmaceuticals. Since health insurance is compulsory, all the population is covered.”

Source: OECD/European Observatory on Health Systems and Policies (2021), Czechia: Country Health Profile 2021, State of Health in the EU, OECD Publishing, Paris/European Observatory on Health Systems and Policies, Brussels.


“Current health expenditure (CHE) in Czechia in 2019 amounted to EUR 18.5 billion (ČSÚ, 2022b). Table 3.1 presents the most recent health expenditure data from WHO and according to these data, CHE as a share of GDP in Czechia in 2019 was 7.8% (up from 5.7% in 2000; see Fig.3.1) and ranked below the EU average of 9.9%. As seen in Fig. 3.2, the increase between 2007 and 2009 is mainly attributed to the sharp decline in GDP during the economic crisis and the fact that HIFs had accumulated enough reserves before to keep spending levels stable or even increase them. After 2009, most countries followed a slight downward trend. During 2010–2011, Czech HIFs came under pressure to decrease spending levels, while health expenditure increases during 2012–2013 were severely restricted by the Reimbursement Directive (see Section 3.3.4). From 2011 to 2015, the funds disbursed by HIFs remained relatively constant and expenditure decreased year-on-year between 2013 and 2016, accounting for inflation (ČSÚ, 2021d).Preliminary data from the OECD for 2020 show that health expenditure data jumped due to the COVID-19 pandemic, with CHE rising to 9.2% of Czechia’s GDP because of policy responses (OECD, 2022a). These additional expenditures were partially financed by a substantial rise in monthly state budget transfers for persons directly insured by the state and continued to rise in 2021 and 2022 (see Section 3.3.2). This increase in CHE’s share of overall GDP is expected to continue after the pandemic.”

Source: Bryndová L, Šlegerová L, Votápková J, Hrobonˇ P, Shuftan N, Spranger A. Czechia: Health system review. Health Systems in Transition, 2023; 25(1): i–183.


“Czechia’s per capita health spending measured in US$ PPP stood at US$ 3477 in 2019 (see Fig.3.3). Lower expenditures, especially when compared with other countries in the WHO European Region, have led to frequent criticism by various stakeholders, including physicians and other health workers, particularly within the context of limiting their pay (see Section 3.7.2).

“The share of CHE from public sources in Czechia, on the other hand, ranked among the highest in the WHO European Region at 81.5% in 2019 (see Fig.3.4) and enables the broad benefits package and virtually universal coverage in Czechia (see Section 3.3.1). With the large expenditure increases from HIFs due to the pandemic, ČSÚ estimates that the share of CHE coming from public sources rose by a near similar three points (as with the drop in private sources) in 2020 (ČSÚ, 2022b).”

Source: Bryndová L, Šlegerová L, Votápková J, Hrobonˇ P, Shuftan N, Spranger A. Czechia: Health system review. Health Systems in Transition, 2023; 25(1): i–183.


“The share of OOP payments of CHE in Czechia is relatively stable and, according to WHO data, hovered around 14% from 2015 to 2019, though ČSÚ data show this share dropping to 11.5% in 2020. OOP payments have accounted for just over 2% of total household expenditure over the same time, and the ČSÚ data furthermore show that OOP payments per capita dropped slightly from CZK5 803 in 2019 to CZK5 666 in 2020 (ČSÚ, 2022b).OOP payments consist of direct payments for over-the-counter pharmaceuticals (26% of OOP payments in 2020); co-payments on prescription pharmaceuticals (20%); above-standard medical procedures and services in both inpatient and outpatient settings (22%, including for spa stays and cosmetic procedures); direct payments and surcharges for dental care (18%); and co-payments on medical aids and other devices (11%) (ČSÚ, 2022b).

“Outpatient and inpatient health services are provided free of charge at the point of use, except for some prescription pharmaceuticals, medical aids and the user fee for accessing outpatient out-of-hours services (CZK90; this fee is not collected if the visit results in a hospital stay). In 2008, more flat user fees were introduced, such as for physician consultations (CZK30), stay per hospital day (CZK60, increased to CZK100 in 2011) and per collected prescription pharmaceutical (CZK30), but were gradually dismantled and fully abolished due to popular and political opposition as of January 2015. No co-payment for “above-standard” medical treatment is possible; should a patient desire an alternative procedure or MDA, they would pay for the whole medical treatment.”

Source: Bryndová L, Šlegerová L, Votápková J, Hrobonˇ P, Shuftan N, Spranger A. Czechia: Health system review. Health Systems in Transition, 2023; 25(1): i–183.


Czech Republic: Health System Expenditures

Czechia Health System Overview
Health System Rankings
Health System Outcomes
Health System Coverage
Costs for Consumers
Health System Expenditures
Health System Financing
Czechia’s COVID-19 Policy

Healthcare Workers
Health System Physical Resources and Utilization
Long-Term Care
Health Information and Communications Technologies
Healthcare Workforce Education & Training
Pharmaceuticals
Wasteful Spending

Political System
Economic System
Population Demographics
People With Disabilities
Aging
Social Determinants & Health Equity
Health System History
Health System Challenges


World Health Systems Facts is a project of the Real Reporting Foundation. We provide reliable statistics and other data from authoritative sources regarding health systems in the US and sixteen other nations.

Page last updated August 4, 2023 by Doug McVay, Editor.

  • Home
  • About World Health Systems Facts
    • Contact Us
    • Join Our Email List
  • Breaking News & Opinion
  • Upcoming Events
  • Seventeen National Health Systems
    • Austria
    • Canada
    • Costa Rica
    • Czechia
    • Denmark
    • France
    • Germany
    • Hungary
    • Italy
    • Japan
    • Netherlands
    • South Korea
    • Spain
    • Sweden
    • Switzerland
    • United Kingdom
    • United States
  • Comparing National Health Systems
    • Healthcare Access and Quality Index
    • Sustainable Development Goals Health Index
    • Mirror Mirror 2021
    • World Health Report 2000
    • International Health Systems In Perspective
    • Lessons for US Health Reform
  • Aging
  • Health System Outcomes
  • Healthcare Spending
  • Healthcare Workforce
    • Healthcare Workers
    • Healthcare Workforce Education & Training
  • Information and Communications Technologies
  • Long-Term Services and Supports
  • People With Disabilities
  • Pharmaceutical Pricing and Regulation
  • Social Determinants & Health Equity
  • Wasteful Healthcare Spending
  • Various US Health System Proposals
    • Affordable Care Act
    • All Payer
    • Public Option
    • Single Payer / “Medicare For All”
    • Universal Health Coverage
  • Recommended Resources
  • Privacy Policy
    • Cookie Policy
  • Facebook
  • LinkedIn
  • Twitter

© 2019-2023 Real Reporting Foundation | Theme by WordPress Theme Detector

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
.
Cookie SettingsAccept
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
_GRECAPTCHA5 months 27 daysThis cookie is set by Google. In addition to certain standard Google cookies, reCAPTCHA sets a necessary cookie (_GRECAPTCHA) when executed for the purpose of providing its risk analysis.
cookielawinfo-checkbox-advertisement1 yearThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Advertisement".
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
CookieDurationDescription
_ga2 yearsThis cookie is installed by Google Analytics. The cookie is used to calculate visitor, session, campaign data and keep track of site usage for the site's analytics report. The cookies store information anonymously and assign a randomly generated number to identify unique visitors.
_gat_UA-71314304-21 minuteThis is a pattern type cookie set by Google Analytics, where the pattern element on the name contains the unique identity number of the account or website it relates to. It appears to be a variation of the _gat cookie which is used to limit the amount of data recorded by Google on high traffic volume websites.
_gcl_au3 monthsThis cookie is used by Google Analytics to understand user interaction with the website.
_gid1 dayThis cookie is installed by Google Analytics. The cookie is used to store information of how visitors use a website and helps in creating an analytics report of how the website is doing. The data collected including the number visitors, the source where they have come from, and the pages visted in an anonymous form.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
CookieDurationDescription
IDE1 year 24 daysUsed by Google DoubleClick and stores information about how the user uses the website and any other advertisement before visiting the website. This is used to present users with ads that are relevant to them according to the user profile.
test_cookie15 minutesThis cookie is set by doubleclick.net. The purpose of the cookie is to determine if the user's browser supports cookies.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
SAVE & ACCEPT
Powered by CookieYes Logo